CLABF OTC
Core One Labs Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -100.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0181
Volume71,759
Avg Volume57,828
Beta0.54
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGareth Manderson
Employees192
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2015-06-25
Websitecore1labs.com
1199 West Hastings Street
Vancouver, BC V6E 3T5
CA
Vancouver, BC V6E 3T5
CA
888-452-6731
About Core One Labs Inc.
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found